• Issue

    Pharmacoepidemiology and Drug Safety: Volume 18, Issue 12

    1125-1252, i-xvi
    December 2009
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Original Reports

Trends of the potentially inappropriate medication consumption over 10 years in older adults in the East of France

Bienvenu Bongue PhD,  Florence Naudin,  Marie-Laure Laroche,  Marie-Madeleine Galteau,  Claire Guy,  René Guéguen,  Jean-Pierre Convers,  Alain Colvez,  Nabil Maarouf, 
  • Pages: 1125-1133
  • First Published: 30 September 2009

NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib

Sebastian Schneeweiss MD, ScD,  Robert J. Glynn PhD, ScD,  Jerry Avorn MD,  Muhammad Mamdani PharmD, MA, MPH,  Helen Mogun MS,  Daniel H. Solomon MD, MPH, 
  • Pages: 1134-1142
  • First Published: 20 October 2009

Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study†

Lennart Welin MD, PhD,  Lars Wilhelmsen MD, PhD,  Arne Björnberg PhD,  Anders Odén PhD, 
  • Pages: 1143-1149
  • First Published: 11 August 2009

Self-medication with antibiotics: questionnaire survey among primary care center attendants†

Mustafa N. Ilhan MD, PhD,  Elif Durukan MD, PhD,  Sevil Özger Ilhan MD, PhD,  F. Nur Aksakal MD,  Seçil Özkan MD,  Mehmet Ali Bumin MD, 
  • Pages: 1150-1157
  • First Published: 13 October 2009

Prescription quality in an acute medical ward†

Nayef A. Alyamani MSc,  Yvonne Hopf MSc,  David J. Williams PhD, FRCPI, FRCPE, 
  • Pages: 1158-1165
  • First Published: 10 August 2009

Trends in long-term opioid therapy for chronic non-cancer pain †

Denise Boudreau RPh, PhD,  Michael Von Korff ScD,  Carolyn M. Rutter PhD,  Kathleen Saunders JD,  G. Thomas Ray MBA,  Mark D. Sullivan MD, PhD,  Cynthia I. Campbell PhD,  Joseph O. Merrill MD, MPH,  Michael J. Silverberg PhD, MPH,  Caleb Banta-Green PhD, MPH, MSW,  Constance Weisner DrPH, MSW, 
  • Pages: 1166-1175
  • First Published: 28 August 2009

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

Gianluca Trifirò MD, MSc,  Antoine Pariente MD, PhD,  Preciosa M. Coloma MD,  Jan A. Kors PhD,  Giovanni Polimeni PharmD, PhD,  Ghada Miremont-Salamé MD,  Maria Antonietta Catania MD,  Francesco Salvo MD,  Anaelle David MD,  Nicholas Moore MD, PhD,  Achille Patrizio Caputi MD,  Miriam Sturkenboom PharmD, PhD,  Mariam Molokhia PhD,  Julia Hippisley-Cox MD,  Carlos Diaz Acedo,  Johan van der Lei MD, PhD,  Annie Fourrier-Reglat PharmD, PhD, 
  • Pages: 1176-1184
  • First Published: 15 September 2009

Evaluating the positive predictive values of antidote signals to detect potential adverse drug reactions (ADRs) in the medical intensive care unit (ICU)†

Sandra L. Kane-Gill Pharm.D, M.Sc, FCCM,  Cassandra J. Bellamy Pharm.D,  Margaret M. Verrico R.Ph,  Steven M. Handler MD, MS, CMD,  Robert J. Weber M.Sc., FASHP, 
  • Pages: 1185-1191
  • First Published: 02 September 2009

Tramadol dependence: a survey of spontaneously reported cases in Sweden

Micaela Tjäderborn MMSc,  Anna K Jönsson PhD,  Johan Ahlner MD, PhD,  Staffan Hägg MD, PhD, 
  • Pages: 1192-1198
  • First Published: 13 October 2009

The effect of selected patient's characteristics on the choice of antihypertensive medication in the elderly in Slovakia †

Martin Wawruch MD, PhD,  Andrej Dukat MD, PhD,  Jan Murin MD, PhD,  Ladislava Wsolova RNDr,  Magdalena Kuzelova PharmD, PhD,  Agata Macugova MD,  Gejza Wimmer Jr RNDr,  Rashmi Shah BSc, MBBS, MD, FRCP, FFPM, 
  • Pages: 1199-1205
  • First Published: 28 August 2009

Polypharmacy in primary care practices: an analysis using a large health insurance database†

Thomas Grimmsmann MD, MPH,  Wolfgang Himmel PhD, 
  • Pages: 1206-1213
  • First Published: 30 September 2009

Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events—a cohort study in 395 039 patients from clinical practice†

Stephen P. Motsko PharmD, PhD,  Stefan Russmann MD,  Eileen E. Ming MPH, ScD,  Varinder P. Singh MS,  Ruby M. Vendiola,  Judith K. Jones MD, PhD, 
  • Pages: 1214-1222
  • First Published: 24 September 2009

Systematic reviews of adverse effects of drug interventions: a survey of their conduct and reporting quality†‡

V. R. Cornelius PhD,  M. J. Perrio PhD,  S. A.W. Shakir FRCP, FFPM, MRCGP,  L. A. Smith PhD, 
  • Pages: 1223-1231
  • First Published: 15 September 2009

Brief Reports

Using health information technology to improve drug monitoring: a systematic review

Geoffrey L. Hayward MD, MPH,  Aaron J. Parnes MD,  Steven R. Simon MD, MPH, 
  • Pages: 1232-1237
  • First Published: 01 September 2009

Case series of liver failure associated with rosiglitazone and pioglitazone†

James S. Floyd MD,  Elizabeth Barbehenn PhD,  Peter Lurie MD, MPH,  Sidney M. Wolfe MD, 
  • Pages: 1238-1243
  • First Published: 22 July 2009

Commentaries

Commentary on ‘case series of liver failure associated with rosiglitazone and pioglitazone’ by Floyd et al.

Suzette Y Osei MD, PhD,  Carol E Koro PhD,  Alexander R Cobitz MD, PhD,  Nikheel S Kolatkar MD, MPH,  Monika Stender Dr sc hum, 
  • Pages: 1244-1246
  • First Published: 04 August 2009

Commentary on ‘case series of liver failure associated with rosiglitazone and pioglitazone’ by James Floyd et al†

Annette B. Beiderbeck PharmD, MSc, PhD,  Motonobu Sakaguchi MSc, 
  • Pages: 1247-1249
  • First Published: 19 October 2009

Letters to the Editor

Outbreaks of severe hypoglycaemia due to illegal sexual enhancement products containing undeclared glibenclamide

Thomas Y. K. Chan MBChB, MD, PhD, 
  • Pages: 1250-1251
  • First Published: 20 November 2009

Announcements

Regional Editor sought for Pharmacoepidemiology and Drug Safety for the Asia-Pacific Region, Middle East and Africa

  • Page: 1252
  • First Published: 20 November 2009

Current Awareness

Current awareness: Pharmacoepidemiology and drug safety

  • Pages: i-xvi
  • First Published: 20 November 2009